| Kuss Physical Therapy Pllc | |
|
124 Us Route 11, Central Square, NY 13036-9760 | |
| (315) 668-0123 | |
| (315) 668-0124 |
| Full Name | Kuss Physical Therapy Pllc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 124 Us Route 11, Central Square, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265590137 | NPI | - | NPPES |
| 02643841 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 012711 (New York) | Primary |
| 225100000X | Physical Therapist | 019046 (New York) | Secondary |
| Provider Name | Jody L Francis |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558335000 PECOS PAC ID: 2062301765 Enrollment ID: I20040311000922 |
News Archive
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that the European Patent Office had notified it of the intention to grant the patent application EP2016183 entitled "Process for chromosome engineering using a novel DNA repair system".
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
[House Speaker John Boehner] said the Supreme Court ruling, which defined the mandate as a tax, strengthened his "resolve" to get rid of the law. "All it really does is strengthen my resolve and resolve of Republicans here in Washington to repeal this awful law," Boehner said.
Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 9 days ago
| Provider Name | John K Kuss |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1285783647 PECOS PAC ID: 2668449596 Enrollment ID: I20040913000232 |
News Archive
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that the European Patent Office had notified it of the intention to grant the patent application EP2016183 entitled "Process for chromosome engineering using a novel DNA repair system".
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
[House Speaker John Boehner] said the Supreme Court ruling, which defined the mandate as a tax, strengthened his "resolve" to get rid of the law. "All it really does is strengthen my resolve and resolve of Republicans here in Washington to repeal this awful law," Boehner said.
Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 9 days ago
| Provider Name | Heidi L Hathaway |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1316096100 PECOS PAC ID: 4082667167 Enrollment ID: I20050301000557 |
News Archive
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that the European Patent Office had notified it of the intention to grant the patent application EP2016183 entitled "Process for chromosome engineering using a novel DNA repair system".
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
[House Speaker John Boehner] said the Supreme Court ruling, which defined the mandate as a tax, strengthened his "resolve" to get rid of the law. "All it really does is strengthen my resolve and resolve of Republicans here in Washington to repeal this awful law," Boehner said.
Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 9 days ago
| Provider Name | Elizabeth E Lannier |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1104095926 PECOS PAC ID: 3870678725 Enrollment ID: I20080317000519 |
News Archive
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that the European Patent Office had notified it of the intention to grant the patent application EP2016183 entitled "Process for chromosome engineering using a novel DNA repair system".
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
[House Speaker John Boehner] said the Supreme Court ruling, which defined the mandate as a tax, strengthened his "resolve" to get rid of the law. "All it really does is strengthen my resolve and resolve of Republicans here in Washington to repeal this awful law," Boehner said.
Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 9 days ago
| Provider Name | Allison A Bronner |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255569646 PECOS PAC ID: 2567642325 Enrollment ID: I20110210000797 |
News Archive
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that the European Patent Office had notified it of the intention to grant the patent application EP2016183 entitled "Process for chromosome engineering using a novel DNA repair system".
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
[House Speaker John Boehner] said the Supreme Court ruling, which defined the mandate as a tax, strengthened his "resolve" to get rid of the law. "All it really does is strengthen my resolve and resolve of Republicans here in Washington to repeal this awful law," Boehner said.
Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 9 days ago
| Provider Name | Lisa R Purdy |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1891017760 PECOS PAC ID: 3971784034 Enrollment ID: I20110222000920 |
News Archive
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that the European Patent Office had notified it of the intention to grant the patent application EP2016183 entitled "Process for chromosome engineering using a novel DNA repair system".
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
[House Speaker John Boehner] said the Supreme Court ruling, which defined the mandate as a tax, strengthened his "resolve" to get rid of the law. "All it really does is strengthen my resolve and resolve of Republicans here in Washington to repeal this awful law," Boehner said.
Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kuss Physical Therapy Pllc 124 Us Route 11, Central Square, NY 13036-9760 Ph: (315) 668-0123 | Kuss Physical Therapy Pllc 124 Us Route 11, Central Square, NY 13036-9760 Ph: (315) 668-0123 |
News Archive
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that the European Patent Office had notified it of the intention to grant the patent application EP2016183 entitled "Process for chromosome engineering using a novel DNA repair system".
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation for its compound perifosine from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of multiple myeloma.
[House Speaker John Boehner] said the Supreme Court ruling, which defined the mandate as a tax, strengthened his "resolve" to get rid of the law. "All it really does is strengthen my resolve and resolve of Republicans here in Washington to repeal this awful law," Boehner said.
Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 9 days ago
Mrs. Elizabeth Ellen Lannier, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 124 Us Route 11, Kuss Physical Therapy, Central Square, NY 13036 Phone: 315-668-0123 | |
David Alan Povlock, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 537 S Main St, Central Square, NY 13036 Phone: 315-668-7141 Fax: 315-668-9855 | |
Allison Amy Bronner, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 124 U.s. Route 11, Central Square, NY 13036 Phone: 315-668-0123 | |
John Kenneth Kuss, PT, DPT, MTC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 124 Us Route 11, Central Square, NY 13036 Phone: 315-668-0123 Fax: 315-668-0124 | |
Heidi Lynne Hathaway, MS, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 124 Us Route 11, Central Square, NY 13036 Phone: 315-668-0123 Fax: 315-668-0124 | |
Mrs. Jennifer Homer Eckardt, MS PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Us Route 11, Central Square, NY 13036 Phone: 315-668-0123 Fax: 315-668-0124 |